Company Name Brand Name GMDN Term Name GMDN Term Status FDA Product Code Name FDA Product Code Device Packaged As Sterile Sterilization Prior To Use Issuing Agency Device Size Device Size Type Device Class Implantable

Show Filters

PulseRider Aneurysm Neck Reconstruction Device, 3.5 to 4.5 mm, 8 mm, T shape
Medos International Sàrl
203-D
Not in Commercial Distribution

  • 00859030005147 ()
203-D

  • Bare-metal intracranial vascular stent
PulseRider Aneurysm Neck Reconstruction Device, 2.7 to 3.5 mm, 10 mm, T shape
Medos International Sàrl
211-D
Not in Commercial Distribution

  • 00859030005130 ()
211-D

  • Bare-metal intracranial vascular stent
Pulsar Vascular PulseRider,3.5 to 4.5mm,10mm,T shape
Medos International Sàrl
213-D
Not in Commercial Distribution

  • 00859030005123 ()
213-D

  • Bare-metal intracranial vascular stent
PulseRider Aneurysm Neck Reconstruction Device, 2.7 to 3.5 mm, 8 mm, Y shape
Medos International Sàrl
301-D
Not in Commercial Distribution

  • 00859030005116 ()
301-D

  • Bare-metal intracranial vascular stent
PulseRider Aneurysm Neck Reconstruction Device, 3.5 to 4.5 mm, 8 mm, Y Shape
Medos International Sàrl
303-D
Not in Commercial Distribution

  • 00859030005109 ()
303-D

  • Bare-metal intracranial vascular stent
PulseRider Aneurysm Neck Reconstruction Device, 2.7 to 3.5 mm, 10 mm, Y shape
Medos International Sàrl
311-D
Not in Commercial Distribution

  • 00859030005093 ()
311-D

  • Bare-metal intracranial vascular stent
PulseRider Aneurysm Neck Reconstruction Device, 3.5 to 4.5 mm, 10 mm, Y shape
Medos International Sàrl
313-D
Not in Commercial Distribution

  • 00859030005086 ()
313-D

  • Bare-metal intracranial vascular stent
The Lixelle(r) beta 2-microglobulin apheresis column is indicated for the treatment of patients with clinically-diagnosed dialysis-related amyloidosis (DRA).
KANEKA CORPORATION
S-35
Not in Commercial Distribution

  • 24993478020239 ()
  • 14993478020232 ()
  • 04993478010045 ()
N/A

  • Haemoperfusion system absorption column
The Lixelle(r) beta 2-microglobulin apheresis column is indicated for the treatment of patients with clinically-diagnosed dialysis-related amyloidosis (DRA).
KANEKA CORPORATION
S-25
Not in Commercial Distribution

  • 24993478020222 ()
  • 14993478020225 ()
  • 04993478010069 ()
N/A

  • Haemoperfusion system absorption column
The Lixelle(r) beta 2-microglobulin apheresis column is indicated for the treatment of patients with clinically-diagnosed dialysis-related amyloidosis (DRA).
KANEKA CORPORATION
S-15
Not in Commercial Distribution

  • 14993478020218 ()
  • 04993478010052 ()
  • 24993478020215 ()
N/A

  • Haemoperfusion system absorption column
< 1 ... 11 12 13 14 15 ... 53 >